| | | | |
CUSIP No. 71722W107 | | Schedule 13G | | Page 13 of 17 |
Not applicable.
(a-c)
The ownership information presented below represents beneficial ownership of Common Stock of the Issuer as of November 7, 2023, based upon 57,252,519 shares of Common Stock outstanding, as disclosed in the Issuer’s Quarterly Report on Form 10-Q as filed with the Securities and Exchange Commission on November 9, 2023.
| | | | | | | | | | | | | | | | | | | | | | | | |
Reporting Person | | Amount beneficially owned | | | Percent of class | | | Sole power to vote or to direct the vote | | | Shared power to vote or to direct the vote | | | Sole power to dispose or to direct the disposition | | | Shared power to dispose or to direct the disposition | |
The Carlyle Group Inc. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Carlyle Holdings I GP Inc. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Carlyle Holdings I GP Sub L.L.C. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Carlyle Holdings I L.P. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
CG Subsidiary Holdings L.L.C. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
TC Group, L.L.C. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Carlyle Investment Management L.L.C. | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Carlyle Genesis UK LLC | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Abingworth LLP | | | 3,496,808 | | | | 6.1 | % | | | 0 | | | | 3,496,808 | | | | 0 | | | | 3,496,808 | |
Abingworth Bioventures 8 LP | | | 2,061,702 | | | | 3.6 | % | | | 0 | | | | 2,061,702 | | | | 0 | | | | 2,061,702 | |
Abingworth Bioventures VII LP | | | 1,435,106 | | | | 2.5 | % | | | 0 | | | | 1,435,106 | | | | 0 | | | | 1,435,106 | |
Abingworth Bioventures 8 LP is the record holder of 2,061,702 shares of Common Stock and Abingworth Bioventures VII LP is the record holder of 1,435,106 shares of Common Stock.
The Carlyle Group Inc., which is a publicly traded entity listed on Nasdaq, is the sole shareholder of Carlyle Holdings I GP Inc., which is the sole member of Carlyle Holdings I GP Sub L.L.C., which is the general partner of Carlyle Holdings I L.P., which, with respect to the securities reported herein, is the managing member of CG Subsidiary Holdings L.L.C., which is the managing member of TC Group, L.L.C., which is the managing member of Carlyle Investment Management L.L.C., which is the sole member of Carlyle Genesis UK LLC, which is the principal member of